Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest.
Lexogen was founded in 2007 with the support of both private capital and public funds. Lexogen is supported by the Austrian Research Promotion Agency FFG, the Austria Wirtschaftsservice AWS, INiTS and the Wirtschaftsagentur Wien.
Lexogen is based in Vienna, Austria, and has a subsidiary in New Hampshire, USA. 50% of Lexogen employees work in R&D.
For more information on the Lexogen product range for Next Generation Sequencing please use the side menu.